Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Terrence W. Norchi currently holds 6,862 shares of Arch Therapeutics, Inc. (ARTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Terrence W. Norchi has been a net buyer of ARTH stock. They have purchased $1.9K and sold $0 worth of shares.
Terrence W. Norchi's most recent insider trade was on Aug 31, 2023, when they purchased 6,862 shares at $0.28 per share.
Terrence W. Norchi serves as Executive at Arch Therapeutics, Inc. (ARTH). They have executed 5 insider transactions totaling $1.9K over their tenure at the company.
Terrence W. Norchi holds the position of Executive at Arch Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Terrence W. Norchi has shown a buying trading pattern, with $1.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Terrence W. Norchi was on Aug 31, 2023, when they purchased $1.9K worth of ARTH shares. This transaction involved 6,862 shares at $0.28 per share.
Terrence W. Norchi currently owns 6,862 shares of Arch Therapeutics, Inc. (ARTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Terrence W. Norchi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Terrence W. Norchi has 5 Form 4 filings on record as an insider at Arch Therapeutics, Inc..
Set alerts for Terrence W. Norchi and 40,000+ other insiders.